NMPA Product

Compound Sulfadiazine Tablets

Product approved by National Medical Products Administration (CN)

Basic Information

Product Name

Compound Sulfadiazine Tablets

Generic Name

复方磺胺嘧啶片

Strength

磺胺嘧啶0.4g,甲氧苄啶50mg

Dosage Form

片剂

Regulatory Information

Approval Number

国药准字H33021763

Approval StatusApproved

Drug Type

化学药品

Approval Date

January 18, 2021

Company Information

Manufacturer浙江东日药业有限公司

Production Company浙江东日药业有限公司

Active Ingredients

Compound Sulfadiazine Tablets

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy